Paul Aliu
Head of Global Governance, CMO
Novartis

Paul is the Head of the Global Governance Office in the cross-divisional Chief Medical Office at Novartis, with responsibility for the oversight, standards, training and systems for compassionate use/expanded access, grants and post-registration medical programs (e.g. Investigator initiated trials, research collaborations, non-interventional and local studies, registries and patient support programs). He has nearly 20 years’ experience in the Pharma industry across multiple therapeutic areas and roles. Prior to joining the pharmaceutical industry, he practised as a clinical pharmacist.

He previously served as an industry representative over a 5-year period on the WHO/Roll-Back Malaria (RBM) case management working group, managed various partnerships (Public-Private & Private-Private), and has been a speaker/panelist at various conferences and stakeholder discussions on Global Health, Patient Access, Bioethics and Medical Governance.

Paul is a member of the Royal Pharmaceutical Society of Great Britain (MRPharmS). He has a Doctorate in Clinical Pharmacy from the University of Florida, a first class honours masters degree in Pharmacy from the Sunderland School of Pharmacy in the UK, a qualifying Law degree from the College of Law in London (now University of Law), a certificate in Global Health Delivery from Harvard University, and an executive MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland.